Join
Live feed
·
PRReleasevia Quantisnow
AstraZeneca PLC logo
Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZeneca

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLCARDS· Aridis Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC), ARDS (Aridis Pharmaceuticals Inc.) and more on Quantisnow.